{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:33:47Z","timestamp":1794004427916,"version":"4.8.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41395-018-0157-x","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T11:02:57Z","timestamp":1529924577000},"page":"1639-1648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm"],"prefix":"10.14309","volume":"113","author":[{"given":"Antonio","family":"Cuadrado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Llerena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Pall\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Pell\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Echevarr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Ayesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Seti\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Lopez-Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicto","family":"Crespo-Facorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Ag\u00fcero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Chueca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210302","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data.","volume":"58","author":"Blachier","year":"2013","journal-title":"J Hepatol"},{"key":"R2-19-20210302","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1157\/13090276","article-title":"Hepatitis C in Spain.","volume":"127","author":"Bruguera","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"R3-19-20210302","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/S0168-8278(17)30857-7","article-title":"Prevalence of hepatitis C in the spanish population. The PREVHEP study (ETHON cohort).","volume":"66","author":"Lavin","year":"2017","journal-title":"J Hepatol"},{"key":"R4-19-20210302","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis.","volume":"58","author":"Larney","year":"2013","journal-title":"Hepatology"},{"key":"R5-19-20210302","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10096-011-1166-5","article-title":"Hepatitis C and B prevalence in Spanish prisons.","volume":"30","author":"Saiz de la Hoya","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R6-19-20210302","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","article-title":"Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.","volume":"388","author":"Dolan","year":"2016","journal-title":"Lancet"},{"key":"R7-19-20210302","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/hep.28609","article-title":"Hepatitis C management in prisons: an insight into daily clinical practice in three major Italian correctional houses.","volume":"64","author":"Foschi","year":"2016","journal-title":"Hepatology"},{"key":"R8-19-20210302","first-page":"S3","article-title":"National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: 2002-June 10-12, 2002.","volume":"36","year":"2002","journal-title":"Hepatology"},{"key":"R9-19-20210302","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5694\/mja13.10654","article-title":"Enhancing hepatitis C treatment in the custodial setting: a national roadmap.","volume":"200","author":"Mina","year":"2014","journal-title":"Med J Aust"},{"key":"R10-19-20210302","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJMp1311941","article-title":"Responding to hepatitis C through the criminal justice system.","volume":"370","author":"Rich","year":"2014","journal-title":"N Engl J Med"},{"key":"R11-19-20210302","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jhep.2017.06.033","article-title":"Micro-elimination - a path to global elimination of hepatitis C.","volume":"67","author":"Lazarus","year":"2017","journal-title":"J Hepatol"},{"key":"R12-19-20210302","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3201\/eid2101.141025","article-title":"Prisoners treated for hepatitis C with protease inhibitor, New York, USA, 2012.","volume":"21","author":"Moorjani","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"R15-19-20210302","doi-asserted-by":"crossref","first-page":"S492","DOI":"10.1016\/S0168-8278(17)31380-6","article-title":"(Project ECHO, University of New Mexico Health Sciences Center, Albuquerque, United States). Treatment of chronic hepatitis C virus (HCV) infections with Direct Acting Antivirals in the New Mexico State Prison System using the Project ECHO Model.","volume":"66","author":"Thornton","year":"2017","journal-title":"J Hepatol"},{"key":"R16-19-20210302","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/molbev\/msp259","article-title":"SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building.","volume":"27","author":"Gouy","year":"2010","journal-title":"Mol Biol Evol"},{"issue":"Suppl 1","key":"R17-19-20210302","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-8278(99)80385-7","article-title":"Nosocomial transmission of hepatitis C virus.","volume":"31","author":"Sanchez-Tapias","year":"1999","journal-title":"J Hepatol"},{"key":"R18-19-20210302","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5694\/j.1326-5377.2010.tb03605.x","article-title":"Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C.","volume":"192","author":"Boonwaat","year":"2010","journal-title":"Med J Aust"},{"key":"R19-19-20210302","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.drugalcdep.2014.11.021","article-title":"High-risk behaviors after release from incarceration among people who inject drugs in St. Petersburg, Russia.","volume":"147","author":"Cepeda","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"R20-19-20210302","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-138-3-200302040-00010","article-title":"Treatment of chronic hepatitis C in a state correctional facility.","volume":"138","author":"Allen","year":"2003","journal-title":"Ann Intern Med"},{"key":"R21-19-20210302","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7326\/M15-0617","article-title":"Prevention of Hepatitis C by screening and treatment in U.S. prisons.","volume":"164","author":"He","year":"2016","journal-title":"Ann Intern Med"},{"key":"R23-19-20210302","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/hep.28497","article-title":"Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis.","volume":"63","author":"Martin","year":"2016","journal-title":"Hepatology"},{"key":"R24-19-20210302","doi-asserted-by":"crossref","first-page":"546","DOI":"10.7326\/M14-0602","article-title":"Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in U.S. incarcerated populations: a cost-effectiveness analysis.","volume":"161","author":"Liu","year":"2014","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"R25-19-20210302","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/00333549071220S214","article-title":"Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico.","volume":"122","author":"Arora","year":"2007","journal-title":"Public Health Rep"},{"key":"R26-19-20210302","first-page":"195097","article-title":"Translational research of telecare for the treatment of hepatitis C.","volume":"2014","author":"Chen","year":"2014","journal-title":"Biomed Res Int"},{"key":"R28-19-20210302","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/jvh.12648","article-title":"Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort.","volume":"24","author":"Alonso","year":"2017","journal-title":"J Viral Hepat"},{"key":"R29-19-20210302","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"Electronic address eee. EASL recommendations on treatment of hepatitis C 2016.","volume":"66","year":"2017","journal-title":"J Hepatol"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0157-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0157-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/00000434-201811000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0157-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:46:22Z","timestamp":1786542382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201811000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1038\/s41395-018-0157-x","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}